$24.780
-0.691 (-2.79%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
CAI 相似图表分析预测
Alphio's CAI stock price prediction model matches the current Caris Life Sciences, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $24.83 (+0.12%). The 1-week path is $24.41 (-1.57%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Caris Life Sciences, Inc. 股票吗?
Caris Life Sciences Inc is a good buy right now due to its recent strong revenue growth and positive market sentiment. The current price is $25.63, and the company's gross margin has improved significantly to 68.10% in Q2 2026, indicating strong profitability potential. Additionally, analysts have set a price target of $30, suggesting a potential upside of 17.5%. However, the main risk is the company's high forward P/E ratio of 60.98, indicating that the stock may be overvalued if growth does not meet expectations.
CAI 股价于 Tuesday 收于 $24.78,此前下跌 -2.79%
Caris Life Sciences, Inc. (CAI) last closed at $24.8, gaining +0.08%. These facts feed the 1-day and 1-week CAI price prediction above.
预测驱动因素
Caris Life Sciences, Inc.(CAI)的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
相似图表形态
近期走势与 CAI 最接近的股票,按相似度排序。
CAI 季节性分析
Historically the probability of a positive September return for CAI is 91.30%. October offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。